| Price | 9.15p on 23-04-2026 at 13:20:14 |
|---|---|
| Change | -0.10p -1.08% |
| Buy | 9.30p |
| Sell | 9.00p |
| Last Trade: | Sell 21,925.00 at 9.09p |
| Day's Volume: | 283,381 |
| Last Close: | 9.25p |
| Open: | 9.25p |
| ISIN: | GB00BYV81293 |
| Day's Range | 9.15p - 9.25p |
| 52wk Range: | 2.25p - 12.35p |
| Market Capitalisation: | £97.76m |
| VWAP: | 9.115169p |
| Shares in Issue: | 1.07b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 21,925 | 9.09p | Ordinary |
13:41:11 - 23-Apr-26 |
| Sell* | 10 | 9.01p | Ordinary |
13:14:19 - 23-Apr-26 |
| Sell* | 10 | 9.01p | Ordinary |
13:03:57 - 23-Apr-26 |
| Sell* | 10 | 9.01p | Ordinary |
13:02:27 - 23-Apr-26 |
| Sell* | 39,067 | 9.025p | Ordinary |
12:47:55 - 23-Apr-26 |
| Buy* | 105 | 9.50p | SI Trade |
12:30:56 - 23-Apr-26 |
| Sell* | 1,667 | 9.00p | SI Trade |
12:30:56 - 23-Apr-26 |
| Sell* | 60,000 | 9.075p | Ordinary |
12:30:38 - 23-Apr-26 |
| Sell* | 1,336 | 9.15p | Ordinary |
12:08:36 - 23-Apr-26 |
| Sell* | 16,095 | 9.075p | Ordinary |
11:46:48 - 23-Apr-26 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 9th Apr 2026 12:30 pm | RNS | Audited results for year ended 31 December 2025 |
| 1st Apr 2026 9:22 am | RNS-R | Publication of Report, Reinforcing FDA Approval |
| 31st Mar 2026 7:03 am | RNS | Total Voting Rights |
| 31st Mar 2026 7:00 am | RNS | EMA approves extension - to include adolescents |
| 3rd Mar 2026 7:00 am | RNS | Chinese NMPA Accepts MAA Submission for ACCRUFeR® |
| 27th Feb 2026 7:00 am | RNS | Total Voting Rights |
| 9th Feb 2026 7:00 am | RNS | FDA Grants additional Exclusivity for ACCRUFeR |
| 30th Jan 2026 7:05 am | RNS | Total Voting Rights |
| 30th Jan 2026 7:00 am | RNS | Approval for ACCRUFeR in China expected in Q1 2026 |
| 21st Jan 2026 7:00 am | RNS | Q4 2025 Trading Update |
